JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB68455

Anti-SKP2 antibody

0

(1 Review)

|

(22 Publications)

Rabbit Polyclonal SKP2 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 22 publications. Immunogen corresponding to Synthetic Peptide within Human SKP2 aa 1-50.

View Alternative Names

FBXL1, SKP2, S-phase kinase-associated protein 2, Cyclin-A/CDK2-associated protein p45, F-box protein Skp2, F-box/LRR-repeat protein 1, p45skp2

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-SKP2 antibody (AB68455)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-SKP2 antibody (AB68455)

Immunofluorescence analysis of SKP2 using Anti-SKP2 antibody. SKP2 was detected in a immunocytochemical section of SiHa cell. Enzyme antigen retrieval was performed using IHC enzyme antigen retrieval reagent for 15 minutes. The cells were blocked with 10% goat serum. The cells were then incubated with 5 μg/mL ab68455 and Mouse anti-Tubulin Alpha antibody overnight at 4°C. DyLight®488 Conjugated Goat Anti-Rabbit IgG and Cy3 Conjugated Goat Anti-Mouse IgG were used as secondary antibodies at 1 : 500 dilution and incubated for 30 minutes at 37°C. Visualized using a fluorescence microscope and filter sets appropriate for the label used.

Flow Cytometry - Anti-SKP2 antibody (AB68455)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-SKP2 antibody (AB68455)

Flow cytometric analysis of 4% paraformaldehyde fixed and permeabilized HepG2 cells. The cells were blocked with 10% normal goat serum, then incubated with ab68455 (1 μg/1x106 cells) for 30 min at 20°C. DyLight®488 conjugated goat anti-rabbit IgG (5-10 μg/1x106 cells) was used as secondary antibody for 30 minutes at 20°C. Isotype control antibody (Green line) was Rabbit IgG (1 μg/1x106) used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.

Western blot - Anti-SKP2 antibody (AB68455)
  • WB

Supplier Data

Western blot - Anti-SKP2 antibody (AB68455)

Blocking buffer : 5% non-fat milk/TBS

All lanes:

Western blot - Anti-SKP2 antibody (ab68455) at 0.5 µg/mL

Lane 1:

Human 293T whole cell lysates at 30 µg

Lane 2:

Human Jurkat whole cell lysates at 30 µg

Lane 3:

Human HepG2 whole cell lysates at 30 µg

Lane 4:

Human MCF-7 whole cell lysates at 30 µg

Secondary

All lanes:

Goat anti-rabbit IgG-HRP secondary antibody at 1/5000 dilution

Observed band size: 48 kDa

false

Western blot - Anti-SKP2 antibody (AB68455)
  • WB

Unknown

Western blot - Anti-SKP2 antibody (AB68455)

The predicted molecular weight of SKP2 is 48 kDa (SwissProt), however we expect to observe a banding pattern at 53 kDa. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.

All lanes:

Western blot - Anti-SKP2 antibody (ab68455) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

HEK293 (Human embryonic kidney cell line) Whole Cell Lysate at 10 µg

Lane 3:

Human placenta tissue lysate - total protein (<a href='/en-us/products/unavailable/human-placenta-tissue-lysate-total-protein-ab29745'>ab29745</a>) at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution

Predicted band size: 47 kDa

Observed band size: 29 kDa,38 kDa,53 kDa

true

Exposure time: 1min

Western blot - Anti-SKP2 antibody (AB68455)
  • WB

CiteAb

Western blot - Anti-SKP2 antibody (AB68455)

SKP2 western blot using anti-SKP2 antibody ab68455. Publication image and figure legend from Ma, X., Zhao, J., et al., 2017, Oncotarget, PubMed 29137415.

ab68455 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab68455 please see the product overview.

UBE2L3 interacted with SCF (Skp2) complex and promoted p27kip1 ubiquitination and proteasomal degradation(A) Knockdown of UBE2L3 in A549 and NCI-H1299 cells promoted the protein level of p27kip1. (B) Overexpression of UBE2L3 in NCI-H460 and HCC827 cells decreased the protein level of p27kip1. (C) The association between UBE2L3 and SCF (Skp2) complex and p27kip1 was confirmed by immunoprecipitation and immunoblot assay. (D) Overexpression of UBE2L3 promoted the ubiquitination and proteasomal degradation of p27kip1. (E, F) The half-life of p27kip1 was evaluated by CHX assay after UBE2L3 overexpression.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Flow Cyt (Intra), ICC/IF, WB

applications

Immunogen

Synthetic Peptide within Human SKP2 aa 1-50. The exact immunogen used to generate this antibody is proprietary information.

Q13309

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.5 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1 µg for 10^6 Cells", "FlowCytIntra-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Constituents: 76.92% Trehalose, 17.31% Sodium chloride, 3.85% Disodium hydrogenorthophosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

S-phase kinase-associated protein 2 (SKP2) also known as FBL1 or p45 is an E3 ubiquitin ligase that tags proteins for degradation. It weighs around 48 kDa. SKP2 facilitates the transition from the G1 to S phase of the cell cycle by targeting cyclin-dependent kinase inhibitors for proteasomal destruction. Expressed in various tissues including key roles in proliferating cells SKP2 ensures the regulation of cell cycle progression and stability.
Biological function summary

SKP2 is part of the SCF (SKP1-CUL1-F-box) complex which is instrumental in controlling cell cycle and cell division. It regulates the degradation of p27^Kip1 and other cell cycle regulators. By modulating proteolysis SKP2 contributes to the maintenance of cell proliferation and it has essential roles in cellular responses to growth signals. Moreover SKP2 influences processes such as DNA replication through its effect on substrate interaction and ubiquitination.

Pathways

SKP2 functions inside the ubiquitin-proteasome system and impacts the PI3K/AKT signaling pathway. SKP2 advances cell cycle progression by associating with proteins like p27^Kip1 and CDK2 facilitating cell division. It modulates the phosphorylation state of numerous targets influencing signaling processes that control cell growth. This involvement aligns SKP2 with key cellular pathways that maintain cell survival and metabolic balance.

SKP2 plays an important role in cancer and cardiovascular diseases. In various cancers the aberrant expression of SKP2 connects to excessive cell proliferation and tumor growth partially through interactions with oncoproteins like Myc. In cardiovascular conditions SKP2 influences cardiac hypertrophy and might link to proteins such as cyclin-dependent kinase inhibitors. The regulation by SKP2 affects these proteins' stability impacting disease progression and potential therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins involved in cell cycle progression, signal transduction and transcription (PubMed : 11931757, PubMed : 12435635, PubMed : 12769844, PubMed : 12840033, PubMed : 15342634, PubMed : 15668399, PubMed : 15949444, PubMed : 16103164, PubMed : 16262255, PubMed : 16581786, PubMed : 16951159, PubMed : 17908926, PubMed : 17962192, PubMed : 22464731, PubMed : 22770219, PubMed : 32267835). Specifically recognizes phosphorylated CDKN1B/p27kip and is involved in regulation of G1/S transition (By similarity). Degradation of CDKN1B/p27kip also requires CKS1 (By similarity). Recognizes target proteins ORC1, CDT1, RBL2, KMT2A/MLL1, CDK9, RAG2, NBN, FOXO1, UBP43, YTHDF2, and probably MYC, TOB1 and TAL1 (PubMed : 11931757, PubMed : 12435635, PubMed : 12769844, PubMed : 12840033, PubMed : 15342634, PubMed : 15668399, PubMed : 15949444, PubMed : 16103164, PubMed : 16581786, PubMed : 16951159, PubMed : 17908926, PubMed : 17962192, PubMed : 22464731, PubMed : 32267835). Degradation of TAL1 also requires STUB1 (PubMed : 17962192). Recognizes CDKN1A in association with CCNE1 or CCNE2 and CDK2 (PubMed : 16262255). Promotes ubiquitination and destruction of CDH1 in a CK1-dependent manner, thereby regulating cell migration (PubMed : 22770219). Following phosphorylation in response to DNA damage, mediates 'Lys-63'-linked ubiquitination of NBN, promoting ATM recruitment to DNA damage sites and DNA repair via homologous recombination (PubMed : 22464731).. Through the ubiquitin-mediated proteasomal degradation of hepatitis C virus non-structural protein 5A, has an antiviral activity towards that virus.
See full target information SKP2

Publications (22)

Recent publications for all applications. Explore the full list and refine your search

BMC cancer 25:1304 PubMed40790564

2025

SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Pengxiang Yu,Jiarong Li,Wei Feng,Tao Lei,Wen Jia,Yun He,Yang Bi

Cancers 14: PubMed36010941

2022

Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Applications

Unspecified application

Species

Unspecified reactive species

Javier Octavio Mejía-Hernández,Dinesh Raghu,Franco Caramia,Nicholas Clemons,Kenji Fujihara,Thomas Riseborough,Amina Teunisse,Aart G Jochemsen,Lars Abrahmsén,Giovanni Blandino,Andrea Russo,Cristina Gamell,Stephen B Fox,Catherine Mitchell,Elena A Takano,David Byrne,Panimaya Jeffreena Miranda,Reem Saleh,Heather Thorne,Shahneen Sandhu,Scott G Williams,Simon P Keam,Ygal Haupt,Sue Haupt

Frontiers in cardiovascular medicine 9:695004 PubMed35865382

2022

Cardioprotective Effect of Paeonol on Chronic Heart Failure Induced by Doxorubicin Regulating the miR-21-5p/S-Phase Kinase-Associated Protein 2 Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Cong Chen,Shuhong Liu,Gaozhen Cao,Yang Hu,Run Wang,Min Wu,Mingya Liu,Kai Hang Yiu

Journal of biochemical and molecular toxicology 36:e23044 PubMed35499365

2022

Effects of dexmedetomidine on cognitive dysfunction and neuroinflammation via the HDAC2/HIF-1α/PFKFB3 axis in a murine model of postoperative cognitive dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Fang Liu,Rui Hu,Long-Fei Zhang,Yong Fan,Ji-Feng Xiao,Xing-Zhi Liao

Journal of cellular and molecular medicine 25:9214-9227 PubMed34428336

2021

MicroRNA-205-5p targets E2F1 to promote autophagy and inhibit pulmonary fibrosis in silicosis through impairing SKP2-mediated Beclin1 ubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Qingzeng Qian,Qinghua Ma,Bin Wang,Qingqiang Qian,Changsong Zhao,Fumin Feng,Xiaona Dong

Journal of immunology (Baltimore, Md. : 1950) 206:2366-2375 PubMed33837090

2021

SKP2-Promoted Ubiquitination of FOXO3 Promotes the Development of Asthma.

Applications

Unspecified application

Species

Unspecified reactive species

Bing Liu,Junxia Wang,Zhijuan Ren

Journal of experimental & clinical cancer research 39:190 PubMed32938489

2020

IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Zhang,Dawei Wang,Boke Liu,Xingwei Jin,Xianjin Wang,Junwei Pan,Weichao Tu,Yuan Shao

Drug design, development and therapy 14:993-1001 PubMed32184568

2020

Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Chengjiang Qiu,Kairui Liu,Sheng Zhang,Simin Gao,Weirun Chen,Dateng Li,Youxing Huang

Nature communications 11:24 PubMed31911655

2020

The RepID-CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Sang-Min Jang,Jenny F Nathans,Haiqing Fu,Christophe E Redon,Lisa M Jenkins,Bhushan L Thakur,Lőrinc S Pongor,Adrian M Baris,Jacob M Gross,Maura J OʹNeill,Fred E Indig,Steven D Cappell,Mirit I Aladjem

International journal of oncology 56:232-242 PubMed31789387

2019

Interaction of YAP1 and mTOR promotes bladder cancer progression.

Applications

Unspecified application

Species

Unspecified reactive species

Mingxi Xu,Meng Gu,Juan Zhou,Jun Da,Zhong Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com